MedTrace Logo

Tracking Renal Tumors After Cryoablation Evaluation

NCT01117779 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 246

Last updated 2024-01-19

Study results available
· View outcomes & findings →

Summary

TRACE is an observational, open-label, single-arm, multi-center registry of subjects who have undergone renal lesion cryoablation per their physician's standard of care. Patients 18 years of age or older who have been determined to be an appropriate candidate for cryoablation will be offered enrollment into the registry. Subjects will be observed for five years from the date of their cryoablation procedure.

Conditions

  • Kidney Neoplasms

Interventions

DEVICE

Cryoablation

Cryoablation (freezing) with Galil Medical cryoablation systems and needles under imaging guidance

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Stephen Savage, MD · Medical University of South Carolina

  • Peter Clark, MD · Wake Forest University Health Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-09
Primary Completion
2020-11-24
Completion
2020-11-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01117779 on ClinicalTrials.gov